Overview

Yangzheng Compound Mixture in the Treatment of Sleep Disorder in Cancer Patients

Status:
Recruiting
Trial end date:
2022-10-31
Target enrollment:
Participant gender:
Summary
This is a nationwide, multicenter, randomized, prospective, real-world study. The purpose of this study is to evaluate the effect and safety of Yangzheng Compound Mixture in the treatment of sleep disorder in cancer patients with Qi-Yin deficiency syndrome during chemotherapy.
Phase:
Phase 4
Details
Lead Sponsor:
ShuGuang Hospital
Collaborators:
LinkDoc Technology (Beijing) Co. Ltd.
Shaanxi Buchang Pharmaceutical Co., Ltd